Morillas Montserrat, Gómez-Puertas Paulino, Bentebibel Assia, Sellés Eva, Casals Nuria, Valencia Alfonso, Hegardt Fausto G, Asins Guillermina, Serra Dolors
Department of Biochemistry and Molecular Biology, University of Barcelona, School of Pharmacy, E-08028 Barcelona, Spain.
J Biol Chem. 2003 Mar 14;278(11):9058-63. doi: 10.1074/jbc.M209999200. Epub 2002 Dec 23.
Carnitine palmitoyltransferase (CPT) I, which catalyzes the conversion of palmitoyl-CoA to palmitoylcarnitine facilitating its transport through the mitochondrial membranes, is inhibited by malonyl-CoA. By using the SequenceSpace algorithm program to identify amino acids that participate in malonyl-CoA inhibition in all carnitine acyltransferases, we found 5 conserved amino acids (Thr(314), Asn(464), Ala(478), Met(593), and Cys(608), rat liver CPT I coordinates) common to inhibitable malonyl-CoA acyltransferases (carnitine octanoyltransferase and CPT I), and absent in noninhibitable malonyl-CoA acyltransferases (CPT II, carnitine acetyltransferase (CAT) and choline acetyltransferase (ChAT)). To determine the role of these amino acid residues in malonyl-CoA inhibition, we prepared the quintuple mutant CPT I T314S/N464D/A478G/M593S/C608A as well as five single mutants CPT I T314S, N464D, A478G, M593S, and C608A. In each case the CPT I amino acid selected was mutated to that present in the same homologous position in CPT II, CAT, and ChAT. Because mutant M593S nearly abolished the sensitivity to malonyl-CoA, two other Met(593) mutants were prepared: M593A and M593E. The catalytic efficiency (V(max)/K(m)) of CPT I in mutants A478G and C608A and all Met(593) mutants toward carnitine as substrate was clearly increased. In those CPT I proteins in which Met(593) had been mutated, the malonyl-CoA sensitivity was nearly abolished. Mutations in Ala(478), Cys(608), and Thr(314) to their homologous amino acid residues in CPT II, CAT, and ChAT caused various decreases in malonyl-CoA sensitivity. Ala(478) is located in the structural model of CPT I near the catalytic site and participates in the binding of malonyl-CoA in the low affinity site (Morillas, M., Gómez-Puertas, P., Rubi, B., Clotet, J., Ariño, J., Valencia, A., Hegardt, F. G., Serra, D., and Asins, G. (2002) J. Biol. Chem. 277, 11473-11480). Met(593) may participate in the interaction of malonyl-CoA in the second affinity site, whose location has not been reported.
肉碱棕榈酰转移酶(CPT)I催化棕榈酰辅酶A转化为棕榈酰肉碱,促进其通过线粒体膜运输,它受到丙二酰辅酶A的抑制。通过使用SequenceSpace算法程序来识别所有肉碱酰基转移酶中参与丙二酰辅酶A抑制作用的氨基酸,我们发现了5个保守氨基酸(苏氨酸(314)、天冬酰胺(464)、丙氨酸(478)、甲硫氨酸(593)和半胱氨酸(608),以大鼠肝脏CPT I的坐标为准),这些氨基酸存在于可被抑制的丙二酰辅酶A酰基转移酶(肉碱辛酰转移酶和CPT I)中,而在不可被抑制的丙二酰辅酶A酰基转移酶(CPT II、肉碱乙酰转移酶(CAT)和胆碱乙酰转移酶(ChAT))中不存在。为了确定这些氨基酸残基在丙二酰辅酶A抑制中的作用,我们制备了五重突变体CPT I T314S/N464D/A478G/M593S/C608A以及五个单突变体CPT I T314S、N464D、A478G、M593S和C608A。在每种情况下,所选择的CPT I氨基酸都被突变为CPT II、CAT和ChAT中相同同源位置的氨基酸。由于突变体M593S几乎消除了对丙二酰辅酶A的敏感性,因此制备了另外两个甲硫氨酸(593)突变体:M593A和M593E。突变体A478G和C608A以及所有甲硫氨酸(593)突变体中CPT I以肉碱为底物的催化效率(V(max)/K(m))明显提高。在那些甲硫氨酸(593)已发生突变的CPT I蛋白中,对丙二酰辅酶A的敏感性几乎消除。丙氨酸(478)、半胱氨酸(608)和苏氨酸(314)突变为CPT II、CAT和ChAT中的同源氨基酸残基会导致丙二酰辅酶A敏感性出现不同程度的降低。丙氨酸(478)位于CPT I的结构模型中靠近催化位点的位置,并参与低亲和力位点中丙二酰辅酶A的结合(莫里利亚斯,M.,戈麦斯 - 普尔塔斯,P.,鲁比,B.,克洛泰特,J.,阿里尼奥,J.,巴伦西亚,A.,赫加德特,F.G.,塞拉,D.,和阿辛斯,G.(2002年)《生物化学杂志》277,11473 - 11480)。甲硫氨酸(593)可能参与第二个亲和力位点中丙二酰辅酶A的相互作用,该位点的位置尚未报道。